Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CSCO vs MRNA✓SelectedUSD · MRNACSCO vs MRNA performance historyLatest closeAs of+2.18%11/18
Stock and ETF performance explorer

CSCO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+107.8%
MRNA return
-20.0%
Excess return
+127.8%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.2%-4.8%+7.0%+2.3%
7D-3.6%-20.9%+17.3%-2.9%
30D-8.8%-13.3%+4.5%-8.4%
3M-12.6%+212.6%-225.2%-17.1%
6M-17.6%+309.0%-326.7%-24.1%
YTD+28.5%+567.3%-538.8%+13.0%
1Y+27.9%+689.7%-661.8%+10.8%
3Y+119.5%+157.4%-37.9%+100.8%
5Y+107.8%-21.7%+129.5%+99.2%
All+107.8%-20.0%+127.8%+99.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling